Changes related to "Docetaxel (Taxotere)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 22:52, 22 September 2018
   
Page name:

22 September 2018

 m   21:43  Breast cancer‎‎ (3 changes | history) . . (+2,247). . [Jwarner‎ (3×)]
 m    21:43 (cur | prev) . . (+223). . Jwarner (talk | contribs) (EC {{#subobject:8d8dbe|Regimen=1}})
 m    10:14 (cur | prev) . . (+1,007). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:4f9e89|Regimen=1}})
 m    10:13 (cur | prev) . . (+1,017). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:8a2b88|Regimen=1}})
 m   19:33  Prostate cancer‎ (diff | hist) . . (+10,784). . Jwarner (talk | contribs)
 m   16:14  Soft tissue sarcoma‎‎ (2 changes | history) . . (+2,151). . [Jwarner‎ (2×)]
 m    16:14 (cur | prev) . . (+707). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}})
 m    16:08 (cur | prev) . . (+1,444). . Jwarner (talk | contribs) (Doxorubicin & Ifosfamide (AIM) {{#subobject:e28770|Regimen=1}})
     15:50  Ovarian cancer‎ (diff | hist) . . (+2,619). . Jwarner (talk | contribs)

21 September 2018

 m   22:00  Non-small cell lung cancer‎ (diff | hist) . . (+1,109). . Jwarner (talk | contribs) (Cisplatin & Vinorelbine {{#subobject:bdd6b2|Regimen=1}})
 m   20:47  Breast cancer‎‎ (2 changes | history) . . (+3,307). . [Jwarner‎ (2×)]
 m    20:47 (cur | prev) . . (+1,199). . Jwarner (talk | contribs) (FEC {{#subobject:ed96e7|Regimen=1}})
 m    14:46 (cur | prev) . . (+2,108). . Jwarner (talk | contribs) (ddFEC {{#subobject:45dbc1|Regimen=1}})

20 September 2018

 m   16:58  Breast cancer‎‎ (2 changes | history) . . (+1,470). . [Jwarner‎ (2×)]
 m    16:58 (cur | prev) . . (+1,194). . Jwarner (talk | contribs)
 m    16:29 (cur | prev) . . (+276). . Jwarner (talk | contribs) (St Gallen Breast Guidelines)

19 September 2018

 m   22:17  Ovarian cancer‎‎ (4 changes | history) . . (+4,865). . [Jwarner‎ (4×)]
 m    22:17 (cur | prev) . . (+1,552). . Jwarner (talk | contribs) (Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
 m    20:00 (cur | prev) . . (+1,262). . Jwarner (talk | contribs) (Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
 m    19:47 (cur | prev) . . (+1,337). . Jwarner (talk | contribs) (Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
 m    19:39 (cur | prev) . . (+714). . Jwarner (talk | contribs) (Cisplatin & Paclitaxel {{#subobject:d05939|Regimen=1}})
 m   22:02  Melanoma‎ (diff | hist) . . (+2,742). . Jwarner (talk | contribs) (Cisplatin, Dacarbazine +/- Carmustine {{#subobject:1c1243|Regimen=1}})
 m   20:16  Gastric cancer‎‎ (3 changes | history) . . (+603). . [Jwarner‎ (3×)]
 m    20:16 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)
 m    20:15 (cur | prev) . . (+17). . Jwarner (talk | contribs) (References)
 m    20:13 (cur | prev) . . (+570). . Jwarner (talk | contribs) (FAMTX {{#subobject:53382f|Regimen=1}})

18 September 2018

 m   19:42  Ovarian cancer‎ (diff | hist) . . (+1,947). . Jwarner (talk | contribs) (First-line chemotherapy for advanced/metastatic disease)
 m   16:32  Melanoma‎ (diff | hist) . . (+249). . Jwarner (talk | contribs) (Ipilimumab & Nivolumab {{#subobject:517ff0|Regimen=1}})

17 September 2018

 m   22:51  Prostate cancer‎ (diff | hist) . . (0). . Jwarner (talk | contribs) (Apalutamide monotherapy {{#subobject:a70eae |Regimen=1}})
 m   22:14  Non-small cell lung cancer‎ (diff | hist) . . (+6). . Warner-admin (talk | contribs) (Text replacement - "Subset analysis''':" to "Subgroup analysis:'''")
 m   22:11  Ovarian cancer‎ (diff | hist) . . (+1,359). . Jwarner (talk | contribs) (Carboplatin & Docetaxel {{#subobject:8cd1bc|Regimen=1}})
 m   21:59  Melanoma‎ (diff | hist) . . (+532). . Jwarner (talk | contribs) (Pembrolizumab monotherapy {{#subobject:78d8cc|Regimen=1}})

16 September 2018

 m   20:11  Head and neck cancer‎‎ (5 changes | history) . . (+3,020). . [Jwarner‎ (5×)]
 m    20:11 (cur | prev) . . (+2,169). . Jwarner (talk | contribs) (Radiation therapy {{#subobject:5ac377|Regimen=1}})
 m    20:07 (cur | prev) . . (+121). . Jwarner (talk | contribs) (Fluorouracil & RT {{#subobject:3a644e|Regimen=1}})
 m    20:01 (cur | prev) . . (+452). . Jwarner (talk | contribs) (Fluorouracil & RT {{#subobject:3a644e|Regimen=1}})
 m    19:48 (cur | prev) . . (+43). . Jwarner (talk | contribs) (Variant #4, 100/5000 x 4 {{#subobject:23fcf5|Variant=1}})
 m    19:35 (cur | prev) . . (+235). . Jwarner (talk | contribs)
 m   16:30  Soft tissue sarcoma‎ (diff | hist) . . (+582). . Jwarner (talk | contribs) (Docetaxel & Gemcitabine {{#subobject:1e718f|Regimen=1}})
 m   16:22  Small cell lung cancer‎ (diff | hist) . . (+1,200). . Jwarner (talk | contribs) (ACE {{#subobject:9fbf31|Regimen=1}})
 m   12:55  Penile cancer‎ (diff | hist) . . (0). . Jwarner (talk | contribs)
     12:53  Prostate cancer‎‎ (2 changes | history) . . (+1,813). . [Jwarner‎; PeterYang‎]
 m    12:53 (cur | prev) . . (-1). . Jwarner (talk | contribs) (References)
      12:10 (cur | prev) . . (+1,814). . PeterYang (talk | contribs) (added apalutamide)
 m   12:40  Breast cancer‎ (diff | hist) . . (+1,267). . Jwarner (talk | contribs) (Variant #16, 1200/50/1200 x 6 {{#subobject:d46835|Variant=1}})
 m   12:34  Bladder cancer‎‎ (2 changes | history) . . (+33). . [Jwarner‎ (2×)]
 m    12:34 (cur | prev) . . (+17). . Jwarner (talk | contribs)
 m    12:31 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)